Skip to main content

Table 3 MACE terms

From: Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis

Acute myocardial infarction*

Haemorrhagic cerebral infarction

Basal ganglia infarction

Haemorrhagic stroke*

Basilar artery thrombosis

Haemorrhagic transformation stroke

Brain stem infarction*

Ischaemic cerebral infarction

Brain stem stroke

Ischaemic stroke*

Brain stem thrombosis

Lacunar infarction*

Carotid arterial embolus

Lateral medullary syndrome

Carotid artery thrombosis

Moyamoya disease

Cerebellar artery thrombosis

Myocardial infarction*

Cerebellar embolism

Papillary muscle infarction

Cerebellar infarction*

Post procedural myocardial infarction

Cerebral artery embolism

Post procedural stroke

Cerebral artery thrombosis

Silent myocardial infarction*

Cerebral infarction*

Stroke in evolution

Cerebral thrombosis

Sudden cardiac death*

Cerebrovascular accident*

Thalamic infarction*

Coronary artery thrombosis

Thrombotic cerebral infarction

Coronary bypass thrombosis

Thrombotic stroke

Embolic cerebral infarction

Wallenberg syndrome

Embolic stroke

Â